The largest Phase 2b trial used 0.25, 0.5, and 1 mg per day for 24 weeks, but it missed its main weight-loss endpoint
Fatigue, weakness, especially lightning bolt sensations type of pain, joint pain, muscle pain, cognitive impairment, anxiety unrelated to stressors (eg a physical anxiety without a life trigger), depersonalization / derealization, depression, skin sensitivity, emotional lability, thermal lability, vertigo, dizziness, nausea, vomiting - and more
On top of this, DPP-4 is a functional unit consisting of two identical DPP-4 proteins attached to each other forming a dimer
Can you take NAD+ and 5-Amino-1MQ together
Nowadays, LY3502790 and PF-06882961 (231233), a class of oral non-peptide small molecule GLP-1RAs with preferable efficacy and anti-diabetes potential, are at the stage of pre-clinical research